TerminatedPhase 2NCT02286284

Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Bassam HADDAD, M.D
CHIC Creteil
Intervention
Apheresis for extracorporal removal of sFlt-1(device)
Enrollment
2 target
Eligibility
18-45 years · FEMALE
Timeline
20152015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02286284 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials